An investigational IL-5 antagonist, in patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA) (Churg Strauss Syndrome).
GlaxoSmithKline (GSK) today announced the s... - Vasculitis UK
GlaxoSmithKline (GSK) today announced the start of a Phase III study to evaluate the efficacy and safety of mepolizumab,
Written by
Suzym2u
Moderator
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Whoo Hoooo! Although I hope I never need it....fingers crossed. It's good to have as back up though.